Abstract
Publisher's Note: There is a Blood Commentary on this article in this issue.
Publication types
-
Letter
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Crizotinib / pharmacology*
-
Humans
-
Mice
-
Mice, Transgenic
-
Oncogene Proteins, Fusion* / antagonists & inhibitors
-
Oncogene Proteins, Fusion* / genetics
-
Oncogene Proteins, Fusion* / metabolism
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / genetics
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / metabolism
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / pathology
-
Protein Kinase Inhibitors / pharmacology*
Substances
-
ETV6-NTRK3 fusion protein, mouse
-
Oncogene Proteins, Fusion
-
Protein Kinase Inhibitors
-
Crizotinib